Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity
ABSTRACT: Introduction: Cervical cancer is characterized by an immunosuppressive microenvironment and a Th2-type cytokine profile. Expression of arginase (ASE), the enzyme that converts L-arginine into L-ornithine and urea, is stimulated by Th2-type cytokines. Objective: To assess the association of...
- Autores:
-
Bedoya, Astrid Milena
Tate, David
Baena Zapata, Armando
Córdoba Gómez, Carlos Mario
Borrero Franco, Mauricio
Pareja, René
Rojas, Fredy
Patterson, John
Herrero, Rolando
Zea, Arnold
Sánchez Vásquez, Gloria Inés
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2014
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/32451
- Acceso en línea:
- https://hdl.handle.net/10495/32451
https://www.sciencedirect.com/science/article/pii/S0090825814012190?via%3Dihub
- Palabra clave:
- Uterine Cervical Neoplasms
Neoplasias del Cuello Uterino
Arginase
Arginasa
Arginine
Arginina
Cytokines
Citocinas
Th1-Th2 Balance
Balance Th1 - Th2
Colombia
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id |
UDEA2_35019f6087697f9b568e783520ae2235 |
---|---|
oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/32451 |
network_acronym_str |
UDEA2 |
network_name_str |
Repositorio UdeA |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity |
title |
Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity |
spellingShingle |
Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity Uterine Cervical Neoplasms Neoplasias del Cuello Uterino Arginase Arginasa Arginine Arginina Cytokines Citocinas Th1-Th2 Balance Balance Th1 - Th2 Colombia |
title_short |
Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity |
title_full |
Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity |
title_fullStr |
Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity |
title_full_unstemmed |
Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity |
title_sort |
Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity |
dc.creator.fl_str_mv |
Bedoya, Astrid Milena Tate, David Baena Zapata, Armando Córdoba Gómez, Carlos Mario Borrero Franco, Mauricio Pareja, René Rojas, Fredy Patterson, John Herrero, Rolando Zea, Arnold Sánchez Vásquez, Gloria Inés |
dc.contributor.author.none.fl_str_mv |
Bedoya, Astrid Milena Tate, David Baena Zapata, Armando Córdoba Gómez, Carlos Mario Borrero Franco, Mauricio Pareja, René Rojas, Fredy Patterson, John Herrero, Rolando Zea, Arnold Sánchez Vásquez, Gloria Inés |
dc.subject.decs.none.fl_str_mv |
Uterine Cervical Neoplasms Neoplasias del Cuello Uterino Arginase Arginasa Arginine Arginina Cytokines Citocinas Th1-Th2 Balance Balance Th1 - Th2 Colombia |
topic |
Uterine Cervical Neoplasms Neoplasias del Cuello Uterino Arginase Arginasa Arginine Arginina Cytokines Citocinas Th1-Th2 Balance Balance Th1 - Th2 Colombia |
description |
ABSTRACT: Introduction: Cervical cancer is characterized by an immunosuppressive microenvironment and a Th2-type cytokine profile. Expression of arginase (ASE), the enzyme that converts L-arginine into L-ornithine and urea, is stimulated by Th2-type cytokines. Objective: To assess the association of ASE activity and L-Arg metabolism products with cervical cancer. Methods: Sera of 87 and 41 women with histologically confirmed by colposcopy-directed biopsy SCC and CIN3 respectively and 79 with normal cytology or Low-Grade Squamous Intraepithelial Lesion (LSIL), were evaluated. Cytokines were measured using Milliplex Human cytokine/chemokine kit. Arginase (ASE) activity was determined using an enzymatic assay. Levels of L-arginine, L ornithine, putrescine and spermine were determined by HPLC. Results: Significantly higher levels of ASE activity were observed in women with CIN3 (age-adjusted OR: 24.3; 95%CI: 3.82–155) and SCC (AOR: 9.8; 95%CI: 2.34–40.8). As expected, possibly due to high levels of ASE activity, higher levels of L-Arg were negatively associated with CIN3 (AOR: 0.03; 95%CI: 0.004–0.19) and SSC (AOR: 0.06; 95%CI: 0.02–0.24). Consistent with the role of ASE in the conversion of L-arginine to L-ornithine and polyamine production therefrom, women with cervical cancer had higher levels of spermine and putrescine. A correlation analysis revealed a significant albeit weak relationship between high levels of IL-10 and high levels of ASE (Pearson r = 0.32, p-value = 0.003) in women with cervical cancer. Conclusion: This study indicates that ASE activity and L-Arg degradation mechanisms of immunosuppression are present in cervical cancer. The results foster research in the design of possible strategies to inhibit ASE activity for therapy of cervical cancer. |
publishDate |
2014 |
dc.date.issued.none.fl_str_mv |
2014 |
dc.date.accessioned.none.fl_str_mv |
2022-11-29T21:46:35Z |
dc.date.available.none.fl_str_mv |
2022-11-29T21:46:35Z |
dc.type.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.hasversion.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
dc.type.local.spa.fl_str_mv |
Artículo de investigación |
format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
status_str |
publishedVersion |
dc.identifier.issn.none.fl_str_mv |
0090-8258 |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/32451 |
dc.identifier.doi.none.fl_str_mv |
10.1016/j.ygyno.2014.07.096 |
dc.identifier.eissn.none.fl_str_mv |
1095-6859 |
dc.identifier.url.spa.fl_str_mv |
https://www.sciencedirect.com/science/article/pii/S0090825814012190?via%3Dihub |
identifier_str_mv |
0090-8258 10.1016/j.ygyno.2014.07.096 1095-6859 |
url |
https://hdl.handle.net/10495/32451 https://www.sciencedirect.com/science/article/pii/S0090825814012190?via%3Dihub |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
Gynecol. Oncol. |
dc.rights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ |
dc.rights.accessrights.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.creativecommons.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.format.extent.spa.fl_str_mv |
7 |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Elsevier |
dc.publisher.group.spa.fl_str_mv |
Infección y Cáncer |
dc.publisher.place.spa.fl_str_mv |
Nueva York, Estados Unidos |
institution |
Universidad de Antioquia |
bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/1/BedoyaAstrid_2014_ImmunosuppressionCervicalCancer.pdf https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/2/license_rdf https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/3/license.txt |
bitstream.checksum.fl_str_mv |
859ae06c86a4cb0202e8857f96a59ff6 b88b088d9957e670ce3b3fbe2eedbc13 8a4605be74aa9ea9d79846c1fba20a33 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad de Antioquia |
repository.mail.fl_str_mv |
andres.perez@udea.edu.co |
_version_ |
1812173173017280512 |
spelling |
Bedoya, Astrid MilenaTate, DavidBaena Zapata, ArmandoCórdoba Gómez, Carlos MarioBorrero Franco, MauricioPareja, RenéRojas, FredyPatterson, JohnHerrero, RolandoZea, ArnoldSánchez Vásquez, Gloria Inés2022-11-29T21:46:35Z2022-11-29T21:46:35Z20140090-8258https://hdl.handle.net/10495/3245110.1016/j.ygyno.2014.07.0961095-6859https://www.sciencedirect.com/science/article/pii/S0090825814012190?via%3DihubABSTRACT: Introduction: Cervical cancer is characterized by an immunosuppressive microenvironment and a Th2-type cytokine profile. Expression of arginase (ASE), the enzyme that converts L-arginine into L-ornithine and urea, is stimulated by Th2-type cytokines. Objective: To assess the association of ASE activity and L-Arg metabolism products with cervical cancer. Methods: Sera of 87 and 41 women with histologically confirmed by colposcopy-directed biopsy SCC and CIN3 respectively and 79 with normal cytology or Low-Grade Squamous Intraepithelial Lesion (LSIL), were evaluated. Cytokines were measured using Milliplex Human cytokine/chemokine kit. Arginase (ASE) activity was determined using an enzymatic assay. Levels of L-arginine, L ornithine, putrescine and spermine were determined by HPLC. Results: Significantly higher levels of ASE activity were observed in women with CIN3 (age-adjusted OR: 24.3; 95%CI: 3.82–155) and SCC (AOR: 9.8; 95%CI: 2.34–40.8). As expected, possibly due to high levels of ASE activity, higher levels of L-Arg were negatively associated with CIN3 (AOR: 0.03; 95%CI: 0.004–0.19) and SSC (AOR: 0.06; 95%CI: 0.02–0.24). Consistent with the role of ASE in the conversion of L-arginine to L-ornithine and polyamine production therefrom, women with cervical cancer had higher levels of spermine and putrescine. A correlation analysis revealed a significant albeit weak relationship between high levels of IL-10 and high levels of ASE (Pearson r = 0.32, p-value = 0.003) in women with cervical cancer. Conclusion: This study indicates that ASE activity and L-Arg degradation mechanisms of immunosuppression are present in cervical cancer. The results foster research in the design of possible strategies to inhibit ASE activity for therapy of cervical cancer.COL00123287application/pdfengElsevierInfección y CáncerNueva York, Estados Unidosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Immunosuppression in Cervical Cancer with Special Reference to Arginase ActivityUterine Cervical NeoplasmsNeoplasias del Cuello UterinoArginaseArginasaArginineArgininaCytokinesCitocinasTh1-Th2 BalanceBalance Th1 - Th2ColombiaGynecol. Oncol.Gynecologic Oncology74801351ORIGINALBedoyaAstrid_2014_ImmunosuppressionCervicalCancer.pdfBedoyaAstrid_2014_ImmunosuppressionCervicalCancer.pdfArtículo de investigaciónapplication/pdf434633https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/1/BedoyaAstrid_2014_ImmunosuppressionCervicalCancer.pdf859ae06c86a4cb0202e8857f96a59ff6MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/32451oai:bibliotecadigital.udea.edu.co:10495/324512022-11-29 16:46:35.801Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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 |